Management and Board

Board of Directors


Lucas Decuypere, LLM, MSc. Mgmt and Economics, is the CEO and President of Allegro. A seasoned serial entrepreneur, Lucas has founded and successfully exited multiple ventures, including Localtomorrow and Adagio (now iO). He has consistently driven transformative growth at the intersection of technology and life sciences, and is renowned for his ability to turn bold ideas into market-leading companies, cementing his reputation as one of the foremost innovators in the global business landscape.

Linkedin

dr. Jorg Schelfhout, PhD, holds a Masters degrees in Chemistry and Biomedical Engineering. R&D manager. He spent a decade researching novel biopolymers for tissue regeneration as a postdoc at the PBM Group (Ugent), before switching to roles as R&D manager in the industry. Jorg leads the R&D at Allegro as CSO.

Linkedin

Annie Vereecken, representing Heran BV is a leading biotech investor with early investments in Biocartis, Argenx, Ugentec and Cartagenia. She built out the Medhold group, with a focus on female fertility and pioneering with the NIPT-test. She holds a degree in pharmacy and clinical biology.

dr. Hélène Sabatel, PhD, representing Noshaq SA is a specialized life sciences investment manager. Prior to Noshaq, Hélène held a position as Tech Transfer Officer at the University of Liège. She has extensive experience in the field of IP and business development for life sciences companies.

Linkedin

Advisory Board

Prof. dr. Frank Luyten, MD, MhD is a rheumatologist at UZ Leuven and director of Prometheus. He has been conducting research in regenerative medicine for over twenty years. Frank was a co-founder, scientific and medical advisor of TiGenix.

Mr. Gil Beyen has been a CEO of private and listed biotech companies for more than 20 years. He serves as CEO at Montis and board member at Novadip. Prior to that, he was CEO at ERYTECH Pharma (NSDQ: ERYP) and TiGenix, and Director at Arthur D. Little.

Linkedin

Prof. dr. Yves Henrotin, PT, MT, PhD is a specialist in musculoskeletal disease research and professor at Université Liège. He is the president of the Osteoarthritis Foundation, founder of Artialis, and member of OARSI and ICRS.

Linkedin

Ir. Alexander Van De Rostyne is far and foremost the most unique blend between creativity, engineering and the businessworld. Resulting in countless inventions and business ventures, such as Apple, Planet Internet, The Reference, Deliverect, and the first electric toy helicopter.

Bio